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Abstract
Aim/hypothesis The aim of this study was to investigate the
association between total and types of dairy product intake
and risk of developing incident type 2 diabetes, using a food
diary.
Methods A nested case-cohort within the EPIC-Norfolk
Study was examined, including a random subcohort
(n=4,000) and cases of incident diabetes (n=892, including
143 cases in the subcohort) followed-up for 11 years. Diet was
assessed using a prospective 7-day food diary. Total dairy
intake (g/day) was estimated and categorised into high-fat
(≥3.9%) and low-fat (<3.9% fat) dairy, and by subtype into
yoghurt, cheese and milk. Combined fermented dairy product
intake (yoghurt, cheese, sour cream) was estimated and
categorised into high- and low-fat. Prentice-weighted Cox
regression HRs were calculated.
Results Total dairy, high-fat dairy, milk, cheese and high-fat
fermented dairy product intakes were not associated with the
development of incident diabetes. Low-fat dairy intake was
inversely associated with diabetes in age- and sex-adjusted
analyses (tertile [T] 3 vs T1, HR 0.81 [95% CI 0.66, 0.98]),
but further adjustment for anthropometric, dietary and diabe-
tes risk factors attenuated this association. In addition, an
inverse association was found between diabetes and low-fat
fermented dairy product intake (T3 vs T1, HR 0.76 [95% CI
0.60, 0.99]; ptrend=0.049) and specifically with yoghurt intake
(HR 0.72 [95% CI 0.55, 0.95]; ptrend=0.017) in multivariable
adjusted analyses.
Conclusions/interpretation Greater low-fat fermented dairy
product intake, largely driven by yoghurt intake, was associ-
ated with a decreased risk of type 2 diabetes development in
prospective analyses. These findings suggest that the con-
sumption of specific dairy types may be beneficial for the
prevention of diabetes, highlighting the importance of food
group subtypes for public health messages.
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Introduction
Dairy products are important sources of high-quality protein,
vitamins (A, D [in fortified products], B12, phylloquinones
and menaquinones, and riboflavin) and minerals (calcium,
magnesium and potassium). However, dairy products are also
a source of saturated fats, the intake of which is discouraged in
current dietary guidelines, and it is recommended that saturat-
ed fat intake be replaced with unsaturated fat intake [1]. Dairy
product intake has been associated with a lower risk of type 2
diabetes in three meta-analyses of large prospective epidemi-
ological studies [2–4]. Furthermore, using objective measures,
evidence is emerging that dairy derived fatty acids may have a
protective effect on the risk of diabetes [5, 6].
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Specific dairy subtypes and the intake of low- and high-fat
dairy products have been investigated for independent risks
with incident diabetes [7–11]. We previously reported that
fermented dairy product intake was associated with an inverse
risk of diabetes in a study of eight European countries in the
European Prospective Investigation of Cancer (EPIC)-Interact
study [7]. Furthermore, cheese and fermented dairy products
were shown to have an inverse association with glucose
regulation measures but not with incident diabetes risk in a
study of Danish adults [9]. However, other studies have found
no association of dairy subtypes with type 2 diabetes [8, 10,
11]. None of the recent studies that specifically examined low-
and high-fat dairy reported an association [8, 9, 11]. Nonethe-
less, two meta-analyses showed an inverse association of low-
fat dairy and incident diabetes but a null association of high-
fat dairy intake and disease development [2, 4]. In addition, a
recent review concluded that there is inconsistent evidence to
suggest that high-fat dairy product consumption was associ-
ated with increased risk of incident diabetes [12]. Thus, the
nature of the association between dairy product intake and
type 2 diabetes remains unclear.
To date, research in this area has made use of retrospective
food frequency questionnaires (FFQs) to estimate dairy in-
take. Allowing for standardised responses, FFQs offer a prag-
matic choice as they enable dietary data in large studies to be
collected relatively inexpensively, and are useful in examining
diet–disease relationships as individuals are ranked according
to intake. However, FFQs are limited by the predefined food
lists when analysing type and variety of foods. In addition,
their retrospective nature involves a recall period, often of
12 months, which poses problems of recall bias and related
misreporting error. By contrast, food diaries are not restricted
in the types and amounts of foods that can be recorded at the
time of consumption, reducing recall bias and providing extra
detail which, along with their prospective nature may help to
better investigate the association between risk of diabetes
development and total dairy, low- and high-fat dairy and dairy
subtypes. Currently, no studies on dairy product intake and
type 2 diabetes have made use of food diaries.
The primary aim of this work was to examine the associ-
ations of types and amount of dairy product intake with
incident type 2 diabetes using 7 day food diary data. A
secondary aim was to examine the effect of substituting a
portion of dairy for an alternative food on risk of incident
type 2 diabetes.
Methods
Study design and population The EPIC-Norfolk study, de-
scribed in detail previously [13], is a UK population-based
cohort of 25,639 men and women aged 40–79 years at base-
line, recruited in 1993–1997. All volunteers gave written
informed consent, and the study was approved by the Norfolk
Research Ethics Committee. Participants attended a baseline
health examination at their general practitioner’s clinic, after
which follow-up data collection points included a postal ques-
tionnaire at 18 months, a second health examination visit in
1998–2000 and a postal questionnaire in 2002–2004.
A nested case-cohort was designed, including 4,000
subcohort participants selected at random from the entire
cohort, and 892 incident diabetes cases were ascertained.
Due to the randomly selected nature of the subcohort, 143 of
these cases were included within the subcohort, which the
case-cohort design allows and accounts for in the analysis.
For the current analyses we excluded those with prevalent
and uncertain diabetes status (n=83), those with missing food
diary data (n=18) and other covariates (n=3), and those with
an implausible ratio of energy intake to basal metabolic rate as
defined using published equations [14] (n=82; top and bottom
1% of the distribution). Individuals with prevalent myocardial
infarction, stroke and cancer were also excluded (n=436) to
account for possible post-diagnosis changes in diet. Therefore,
a total of 4,127 participants (753 cases and 3,502 subcohort,
including 128 subcohort cases) remained for analysis.
Case ascertainment and verification Incident type 2 diabetes
cases until 31 July 2006 were ascertained using multiple data
sources, including self-report of doctor-diagnosed diabetes
from the second health check or follow-up health and lifestyle
questionnaires, self-report of diabetes-specific medication in
either of the two follow-up questionnaires or medication
brought to the follow-up health check. These were verified
through record linkage with the general practice diabetes
register, local hospital diabetes register, hospital admissions
data and Office of National Statistics mortality data with
coding for diabetes. Participants who self-reported a history
of diabetes that could not be verified with any other sources of
ascertainment were not included as confirmed cases of
diabetes.
Dietary intake Baseline dietary intake data were collected
using a 7 day food diary [15]. Food weights were estimated
using photographs representing portion sizes, household mea-
sures and standard units. Nurses trained to standardised pro-
tocols provided participants with instructions on how to com-
plete the diary at the health check and asked participants to
recall the previous day’s intake. This formed day one of the
diary. Participants prospectively completed the remaining
6 days and sent it back to the study centre. Food intake data
were entered using the Data into Nutrients for Epidemiologic
Research (DINER) entry system [16] and converted into food
weights and nutrient intakes by DINERMO [17].
A pragmatic approach was applied in estimating dairy
product intake. Total dairy intake was estimated as food items
that only consist of dairy plus composite dishes where dairy
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was the main ingredient. Ice cream, chocolate, butter used in
cooking and dairy included as a minor ingredient in composite
dishes were not included. Intakes were categorised into high-
and low-fat dairy using 3.9% fat (the fat content of whole milk
in the UK) as a cut-off point. Intakes were also categorised by
subtype into yoghurt, cheese and milk intakes. A non-
exclusive group, total fermented dairy products, was created
and subdivided into high- and low-fat fermented dairy
products using 3.9% fat as a cut-off point. Category descrip-
tions are detailed in Table 1.
Covariates Baseline demographic, lifestyle and health char-
acteristics were collected using a self-administered question-
naire. A validated four-point physical activity index was used
to categorise participants as active, moderately active, moder-
ately inactive or inactive [18]. Height, weight, waist circum-
ference and systolic and diastolic BP were measured, BMI
was calculated and blood samples were collected using
standardised procedures. The questionnaires, physical activity
index and anthropometric measurements methods have been
previously described in detail [13]. Dietary covariates were
estimated using data from the 7-day food diary. Plasma vita-
min C measurement is a marker of recent fruit and vegetable
intake [19] and provides an indication of dietary quality. To
determine plasma vitamin C levels, venous blood was drawn
from non-fasting participants into citrate tubes and stored
overnight in a dark container at 4–7°C. Samples were centri-
fuged and plasma was stabilised using a standardised volume
of metaphosphoric acid and measured using a fluorometric
assay.
Statistical analysis Dairy product intakes were divided into
tertiles according to the subcohort intake distribution. Baseline
characteristics and dietary intakes were examined across
tertiles of total dairy intake in the subcohort. Dairy product
intake was adjusted for energy intake using the residual meth-
od [20]. The residuals from the regression of dairy intake on
total energy intake were rescaled by adding the expected dairy
intake for a person with mean total energy intake. By design,
128 incident diabetes cases were included in the random
subcohort. To account for this case-cohort design, Prentice-
weighted Cox regression models [21, 22] were used to calcu-
late HRs and 95%CIs for the association between dairy intake
and incident type 2 diabetes. Age was included as the under-
lying timescale in the Cox models, with entry time defined as
age at recruitment and exit time as age at diagnosis of diabetes,
death, loss to follow-up or censoring at the end of follow-up,
whichever came first.
Model 1 adjusted for age (continuous, as underlying time-
scale) and sex. Model 2 additionally adjusted for BMI
(continuous), family history of diabetes (yes or no), smoking
status (current, former, never), usual alcohol consumption
(continuous units/week) estimated from a health
questionnaire, physical activity index (inactive, moderately
inactive, moderately active, active), social class (professional,
managerial, skilled, semi-skilled, unskilled) and education
level (no qualification, O level, A level, degree or higher).
Model 3 additionally adjusted for dietary covariates, including
energy intake (continuous kJ/day), and intake of fibre,
fruit, vegetables, red meat, processed meat and coffee
(all continuous g/day). To test for linearity the median intake
value of each tertile of dairy intake was included in the Cox
regression model. The assumption of proportional hazards,
checked by including time-dependent covariates in the model,
was not violated. Possible interactions with sex, BMI, physical
activity index and smoking status were examined by including
the interaction terms in the most adjusted models.
The independence of the associations of specific dairy
subtypes was tested by mutually adjusting for other dairy
subtypes and separately for all other food groups. In a further
model, we included hypertension (dichotomous >140 mmHg
systolic BP or >90 mmHg diastolic BP, or on hypertension
medication), hypercholesterolaemia (dichotomous >6.2 mmol/l
or on lipid-lowering medication), sugar-sweetened beverage
intake and trans fat intake. The potential mediating roles of
saturated fat, vitamin D, calcium and magnesium in the asso-
ciation of dairy intake and type 2 diabetes were examined by
entering these into further models. To test the effect of
substituting dairy products for alternative foods, we set a priori
criteria of including only those dairy products that were
associated with type 2 diabetes and considering foods that
would be likely replacements. The effect of substituting a
portion of one food for another was examined by includ-
ing both as continuous variables in a multivariable model
(model 2 plus energy [kJ]). The difference in their beta
coefficients and their variances and covariance were used
to estimate the beta coefficient and variance for the sub-
stitution effect, which in turn was used to calculate HRs
and 95% CIs [23]. Portion sizes are means of those used
in DINERMO [17].
Sensitivity analyses included repeating the models without
the residual method for energy adjustment (i.e. using absolute
intakes), restricting analyses to dairy product consumers only
and including plasma vitamin C levels. In addition, the analy-
ses were repeated excluding participants diagnosed with inci-
dent diabetes in the first 2 years of follow-up in order to
minimise the possibility of reverse causality and those classi-
fied as energy misreporters according to published cut-offs for
the ratio of energy intake to basal metabolic rate [24], and
including those with prevalent chronic diseases at baseline.
Participants with high dairy product intakes were not excluded
as the intakes were deemed plausible and, when examined in
consumers only, no intakes were more than 1 SD higher than
the median.
The analyses were performed using Stata (version 12; Stata
Corp, College Station, TX, USA).
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Results
The largest contributors to dairy intake (g) were milk (81.7%),
cheese (8.7%) and yoghurt (7.6%). The mean (SD) estimated
total dairy intake was 269 g/day (160 g/day) in the subcohort,
and 65% of total dairy intake was from low-fat sources. Those
with higher estimated dairy product intakes were more likely
to be men, have lower BMI and waist circumference (men
only), drink less alcohol, smoke less, be more physically
active, have higher education levels, and have higher intakes
of energy, calcium, magnesium, vitamin D, fibre, fruit and
vegetables and lower intakes of monounsaturated and poly-
unsaturated fat (percentage total energy) and meat (red and
processed; Table 2). Patterns of baseline characteristics were
similar (to those across tertiles of total dairy intake) when
examined across tertiles of milk intake and for the most part
across tertiles of yoghurt intake (electronic supplementary
material [ESM] Table 1). Those with higher amounts of yo-
ghurt consumption were more likely to be women and have
lower intakes of saturated fat (percentage total energy), and
there was no variation with BMI or waist circumference.
Baseline characteristics by tertile of cheese intake showed
no difference in BMI or waist circumference with increasing
intake of cheese, whereas smoking prevalence and monoun-
saturated and polyunsaturated fat intake increased, and these
participants were more likely to consume more alcohol. Dairy
product intakes were not correlated with each other
(Spearman’s ρ all <0.08).
Total dairy, high-fat dairy, milk (whole milk or reduced-fat
milk, data not shown), cheese or high-fat fermented dairy
product intakes (energy-adjusted g/day) were not associated
with the hazard of type 2 diabetes (Table 3). Low-fat dairy
intake was inversely associated with the hazard of type 2
diabetes in model 1 (ptrend=0.025) with an HR of 0.81 (95%
CI 0.66, 0.98) comparing the highest with the lowest tertile of
intake. Adjustment for confounders attenuated the association
to null (model 3 HR 0.92 [95% CI 0.73, 1.17]). Total
fermented dairy product intake was associated with 19%
lower hazard of type 2 diabetes in the age- and sex-adjusted
model. This became non-significant with further adjustment
for potential confounders. When only low-fat fermented dairy
product intake was examined there was a significant inverse
association in adjusted analysis: a comparison of the highest
tertile with the lowest tertile in the most adjusted model gave
an HR of 0.76 (95% CI 0.60, 0.99; ptrend=0.049). Yoghurt
intake was inversely associated with the hazard of diabetes
when adjusted for age and sex (tertile 3 vs tertile 1; HR 0.65
[95% CI 0.52, 0.83]; ptrend<0.001). This lower hazard of
diabetes was maintained through further adjustment for po-
tential confounders (model 3 HR 0.72 [95% CI 0.55, 0.95];
ptrend=0.017).
No interactions of total dairy or dairy subtypes with sex,
BMI, physical activity index or smoking status were evident.
Results were similar for total dairy and dairy subtypes when
BMI was replaced with waist circumference. The indepen-
dence of the associations of dairy subtypes with diabetes was
not affected by adjustment for other dairy subtypes in the
multivariable model. Mutual adjustment for all other food
groups had no effect on the association of low-fat fermented
dairy or yoghurt intake (tertile 3 vs tertile 1). Similarly,
further adjustment of the multivariable model for hyper-
tension, hypercholesterolaemia, sugar-sweetened beverage
intake and trans fat intake did not materially change the
results (not shown). The addition of saturated fat (percent-
age total energy) to the multivariable model marginally
attenuated the associations for intakes of low-fat
fermented dairy products (model 3 HR 0.78 [95% CI
0.61, 1.01]; ptrend=0.058) and yoghurt (model 3 HR 0.73
[95% CI 0.56, 0.95]; ptrend=0.020). When vitamin D,
calcium and magnesium were entered together into a
Table 1 Dairy intake classification: EPIC-Norfolk study
Total dairya Butter, cheese, cream, crème fraîche, dried/powdered milk (made up weight), evaporated
milk, milk, sour cream, yoghurt, baby milk
High-fat dairy (≥3.9% fat) Butter, full fat unripened cheese, all hard, processed and soft cheese, cream, sour cream,
crème fraîche, whole milk, whole dried/powdered milk (made up weight), all evaporated
milk, baby milk
Low-fat dairy (<3.9% fat) Low-fat unripened cheese, semi-skimmed milk, skimmed milk, dried semi-skimmed/
skimmed milk, all yoghurt
Milk Liquid and powdered/dried milk (made up weight); cow, sheep and goat sources
Cheese Hard, processed, soft (e.g. brie) and unripened (e.g. mozzarella, fromage frais, ricotta)
Yoghurt Full-, low-, reduced-, 0%- fat varieties
Total fermented dairy products All yoghurt, all cheese, sour cream and crème fraîche
High-fat fermented dairy products (≥3.9% fat) Hard cheese, soft cheese, high-fat unripened cheese, sour cream, crème fraîche
Low-fat fermented dairy products (<3.9% fat) All yoghurt, low-fat unripened cheeses (e.g. fromage frais, low-fat cottage cheese)
a Estimated as food items that only consist of dairy plus composite dishes where dairy was the main ingredient
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further model the association of total dairy and all dairy
subtypes with type 2 diabetes became marginally more
inverse, but there was no change in the significance of the
associations (results not shown).
Table 4 shows the HRs (95% CI) for substituting one
portion of yoghurt for one portion of an alternative
dessert or snack (described in ESM Table 2). Substituting
yoghurt for snacks was associated with 47% lower haz-
ard of type 2 diabetes. No alternative dessert substitution
was significant.
Sensitivity analyses When the analyses were repeated includ-
ing dairy product consumers only (for each dairy subtype),
associations with incident diabetes became non-significant but
remained in the same direction as for the total sample. Repeating
the analyses using absolute intakes of dairy products, rather than
the energy-adjusted dairy intake, as the main exposure variables
did not materially change the associations, nor did including
plasma vitamin C as an objective marker of dietary quality,
excluding those diagnosed with type 2 diabetes within the first
2 years of follow-up or excluding misreporters of energy intake.
Table 2 Baseline characteristics in the subcohort (n=3,502) by tertile of total dairy intake: EPIC-Norfolk study
Variable Total dairy intake (g/day)a
Tertile 1 (n=1,168) Tertile 2 (n=1,167) Tertile 3 (n=1,167)
≤183 184–312 ≥313 p valueb
Total dairy intake (g/day)c 116±45 245±38 447±134
Anthropometric and socio-demographic characteristics
Mend 473 (40.5) 480 (41.1) 566 (48.5) <0.001
Age (years)c 59±9 59±10 59±9 0.902
Waist circumference (cm)
Menc 97.5±10.5 95.7±9.4 93.9±8.7 <0.001
Womenc 82.4±11.4 81.4±10.49 81.3±9.8 0.125
BMI (kg/m2)c 26.8±4.2 26.2±3.8 25.8±3.5 <0.001
Alcohol (units/week)e 8.5 (1.0, 12.0) 6.6 (1, 9.5) 5.4 (1.0, 7.5) <0.001
Smoking: currentd 163 (14.1) 124 (10.7) 111 (9.6) <0.001
Education: degree or higherd 156 (13.4) 157 (13.5) 164 (14.1) 0.047
Physical activity: actived 182 (15.6) 232 (19.9) 254 (21.8) <0.001
Social class: professional/manageriald 495 (42.4) 509 (43.6) 490 (42.0) 0.709
Dietary intake
Energy (kJ/day)c 7,519±2,092 8,171±2,021 8,912±2,230 <0.001
Saturated fat (% TE)c 12.9±3.1 12.9±3.0 13.1±3.1 0.145
Monounsaturated fat (% TE)c 12.3±2.4 11.9±2.1 11.6±2.0 <0.001
Polyunsaturated fat (% TE)c 6.7±1.8 6.6±1.7 6.2±1.7 <0.001
Calcium (mg/day)c 624±186 807±175 1,077±256 <0.001
Magnesium (mg/day)c 256±75 289±78 330±87 <0.001
Vitamin D (μg/day)e 2.38 (1.53, 3.67) 2.85 (1.83, 4.30) 2.98 (2.07, 4.50) <0.001
Fibre (g/day)c 13.46±4.72 15.04±4.95 16.47±5.90 <0.001
Fruit (g/day)c 141±124 165±131 173±130 <0.001
Vegetables (g/day)e 74 (44, 119) 82 (48, 124) 83 (50, 126) 0.007
Processed meat (g/day)c 30±28 28±24 26±26 0.010
Red meat (g/day)e 11 (0, 30) 13 (0, 25) 9 (0, 23) 0.008
Coffee (g/day)e 304 (80, 598) 301 (64, 477) 271 (46, 582) 0.342
Plasma vitamin C level (μmol/l)c 53±20 54±20 54±20 0.357
a Tertile cut-offs are based on absolute intakes
b p value as calculated using ANOVA or Kruskal–Wallis ANOVA for non-parametric data
cMean ± SD; all values in row
d n (%); all values in row
eMedian (interquartile range); all values in row
TE, total energy
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When participants with prevalent chronic disease (n=436) were
included, the associations were attenuated and only the
association with yoghurt intake remained significant (tertile 3
vs tertile 1, model 3 HR 0.72 [95% CI 0.55, 0.95]).
Table 3 HRs for the association
of dairy product intake and risk of
type 2 diabetes per category of
energy-adjusted dairy product
intake using the residual method:
EPIC-Norfolk Study (n=4,127)
Values are HR (95% CI) except
where indicated otherwise
Model 1: adjusted for age (as
underlying timescale), sex
Model 2: Model 1 plus BMI,
family history of diabetes,
smoking, alcohol, physical
activity index, social class,
education level
Model 3: Model 2 plus energy,
fibre, fruit, vegetables, red meat,
processed meat, coffee intake
a Tertile cut-offs are based on
energy-adjusted intakes in the
subcohort, calculated using the
residual method
bMedian intake (range); all values
in row
Tertile 1a Tertile 2 Tertile 3 ptrend
Total dairy intake (g/day)b 130 (0–190) 246 (190–311) 404 (311–1,544)
Cases/n 278/1,390 240/1,374 234/1,362
Model 1 1 0.89 (0.74,1.08) 0.85 (0.70,1.04) 0.100
Model 2 1 0.93 (0.74,1.18) 1.04 (0.83,1.31) 0.732
Model 3 1 0.94 (0.75,1.19) 1.08 (0.86,1.37) 0.537
High-fat dairy intake (g/day)b 0 (0–19) 35 (19–54) 125 (54–1,095)
Cases/n 257/1,377 205/1,334 291/1,416
Model 1 1 0.90 (0.73,1.11) 1.15 (0.95,1.39) 0.054
Model 2 1 0.76 (0.60,0.98) 1.11 (0.89,1.38) 0.075
Model 3 1 0.76 (0.58,0.98) 1.09 (0.87,1.37) 0.080
Low-fat dairy intake (g/day)b 16 (0–89) 160 (89–230) 325 (230–1,424)
Cases/n 286/1,404 253/1,379 214/1,344
Model 1 1 0.97 (0.80,1.17) 0.81 (0.66,0.98) 0.025
Model 2 1 0.92 (0.74,1.16) 0.89 (0.71,1.11) 0.305
Model 3 1 0.95 (0.76,1.20) 0.92 (0.73,1.17) 0.540
Milk intake (g/day)b 97 (0–150) 201 (150–264) 353 (264–1,518)
Cases/n 271/1,387 242/1,375 238/1,363
Model 1 1 0.89 (0.73,1.08) 0.86 (0.71,1.04) 0.104
Model 2 1 0.94 (0.75,1.18) 1.08 (0.86,1.36) 0.551
Model 3 1 0.95 (0.76,1.20) 1.11 (0.88,1.41) 0.432
Yoghurt intake (g/day)b 0 (0) 21.5 (0.1–44) 80 (44–513)
Cases/n 542/2,698 117/723 94/706
Model 1 1 0.79 (0.63,0.99) 0.65 (0.52,0.83) <0.001
Model 2 1 0.83 (0.63,1.08) 0.70 (0.54,0.91) 0.007
Model 3 1 0.84 (0.64,1.10) 0.72 (0.55,0.95) 0.017
Cheese intake (g/day)b 3 (0–8) 13 (8–20) 32 (20–364)
Cases/n 247/1,371 249/1,366 257/1,390
Model 1 1 0.98 (0.81,1.20) 1.04 (0.86,1.27) 0.623
Model 2 1 1.05 (0.84,1.31) 1.02 (0.81,1.28) 0.946
Model 3 1 1.05 (0.84,1.32) 1.04 (0.83,1.31) 0.760
Total fermented dairy intake (g/day)b 4 (0–13) 23 (13–40) 76 (40–518)
Cases/n 269/1,388 277/1,397 207/1,342
Model 1 1 1.01 (0.84,1.22) 0.81 (0.66,0.98) 0.018
Model 2 1 1.02 (0.82,1.27) 0.82 (0.65,1.04) 0.064
Model 3 1 1.04 (0.84,1.29) 0.85 (0.68,1.08) 0.120
High-fat fermented dairy intake (g/day)b 0 (0) 8 (0.1, 14) 22 (14-185)
Cases/n 194/1,064 283/1,527 276/1,536
Model 1 1 0.96 (0.78,1.18) 0.96 (0.79,1.18) 0.790
Model 2 1 1.19 (0.94,1.51) 1.12 (0.88,1.43) 0.514
Model 3 1 1.23 (0.96,1.57) 1.16 (0.91,1.49) 0.397
Low-fat fermented dairy intake (g/day)b 0 (0) 21 (0.1–43) 80 (43–513)
Cases/n 510/2,538 130/800 113/789
Model 1 1 0.81 (0.66,1.01) 0.72 (0.58,0.90) <0.001
Model 2 1 0.87 (0.67,1.13) 0.74 (0.58,0.96) 0.020
Model 3 1 0.89 (0.69,1.16) 0.76 (0.60,0.99) 0.049
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Discussion
Current findings in context In this prospective study using
dietary intake data from 7-day food diaries, being in the
highest tertile of low-fat fermented dairy product intake
(equivalent to consuming median 80 g/day) was associated
with a 24% decreased risk of developing incident diabetes
compared with being a non-consumer. In public health terms
this equates to 4.5 standard size portions (125 g) per week of
low-fat fermented dairy products, largely comprising of yo-
ghurt (all types) and including low-fat unripened cheese such
as low-fat cottage cheese and fromage frais. This finding was
independent of age, sex, family history of diabetes, BMI,
lifestyle factors and other dietary intakes associated with
diabetes. Total dairy, high-fat dairy, milk, cheese and high-
fat fermented dairy product intakes were not associated with
incident diabetes in these analyses.
Largely owing to its saturated fat content, dairy intake is
conventionally perceived as having an adverse impact on
health outcomes; for instance it is scored as an ‘unhealthy’
item in the Mediterranean diet pattern score [25]. However,
dairy products contain many nutrients including calcium,
vitamin D [26] and magnesium [27] that are considered
healthy constituents of dairy products. Similar to our previ-
ously published work using EPIC-InterAct data [7], the inclu-
sion of these nutrients in our current analyses strengthened the
associations with a lower hazard of type 2 diabetes for all dairy
subtypes, suggesting the presence of other favourable dairy
components. In the current analysis the inclusion of saturated
fat in the most adjusted model marginally attenuated the
hazard of type 2 diabetes, nonetheless associations remained
significant.
Healthy and unhealthy dietary intake habits are known to
cluster, but in this analysis mutually adjusting for other food
groups had no effect on associations. We also examined the
effect of choosing yoghurt (as the only homogenous food
group associated with diabetes in this analysis) instead of an
alternative dessert or snack, to examine the possibility that the
reduction in risk does not come from yoghurt consumption but
from the absence of the alternative food. Replacing a portion
of snacks (crisps) with a portion of yoghurt reduced the hazard
of type 2 diabetes by 47%, suggesting that some of the
association may be attributed to not consuming unhealthy
alternatives.
Intake of total dairy has been reported to be associated with
decreased risk of type 2 diabetes in three meta-analyses [2–4],
but no such association was found in the current study. The
association with some but not all dairy subtypes may explain
this null effect. Findings of recent studies that have focused on
specific dairy subtypes and risk of diabetes are not in accord.
The Whitehall study of London-based men and women in the
civil service showed no relationship between any dairy sub-
type and incident diabetes [8], nor did a prospective study of
Australian adults [10]. Previously, we reported an inverse
association between diabetes and intake of fermented dairy
products, and a marginal inverse association with cheese
intake in the EPIC-InterAct study [7]. Similarly, a study of
Danish adults reported an inverse association of fermented
dairy intake with fasting plasma glucose and HbA1c levels, as
well as cheese intake with incident diabetes and 2 h plasma
glucose levels [9]. In the current study, we report null associ-
ations for total fermented dairy and cheese intakes, but an
inverse association for low-fat fermented dairy intake, which
includes unripened cheese, suggesting that previous findings
from FFQ data may have been driven by low-fat fermented
dairy intakes. Heterogeneity within dairy subtypes between
populations may explain the differences in findings. The
association of low-fat fermented dairy in the current study is
thought to largely be driven by yoghurt intake, as yoghurt
accounted for 87% of low-fat fermented dairy consumed (g)
and, when examined separately, was associated with a 28%
reduced risk of incident diabetes.
Results of the meta-analysis by Tong et al showed low-fat
dairy intake was associated with a larger magnitude of a
decreased risk in type 2 diabetes (combined RR: 0.82 [95%
CI 0.74, 0.90] in a comparison of the highest and lowest intake
categories) compared with total dairy (combined RR 0.86
[95% CI 0.79, 0.92]) [2]. Similar associations were shown in
the meta-analysis by Aune et al in their dose response analysis
(per 400 g total dairy products combined RR 0.93 [95% CI
0.87, 0.99] and per 200 g low-fat dairy products combined RR
0.91 [95% CI 0.86, 0.96]) [4]. Conversely, higher intakes of
low-fat dairy were associated with higher risks of chronic
disease, in particular type 2 diabetes, in a large prospective
study of German adults [28], while regular-fat dairy was
associated with a reduced risk of incident metabolic syndrome
but not diabetes in a study of Australian older adults [11]. In
the current study, low-fat dairy intakes were associated with
Table 4 HRs for risk of type 2 diabetes associated with the substitution
of yoghurt (137 ga) for snacks and desserts: EPIC-Norfolk study
(n=4,127)
Dairy desserts (146 g) 0.69 (0.32, 1.06)
Puddings (138 g) 0.87 (0.21, 1.53)
Cake (76 g) 0.91 (0.49, 1.32)
Biscuits (17 g) 0.77 (0.44, 1.09)
Snacks (32 g) 0.53 (0.23, 0.84)
Creams (23 g) 0.95 (0.40, 1.48)
Chocolate confectionary (25 g) 0.71 (0.39, 1.03)
Other desserts (113 g) 0.83 (0.04, 1.63)
Values are given as HR (95% CI)
HRs are adjusted for age (as underlying timescale), sex, BMI, family
history of diabetes, physical activity index, social class, education level
and energy
aMean portion sizes as used in DINERMO [17]
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lower risk of type 2 diabetes only in the age- and sex-adjusted
analysis and not after further adjustment for anthropometric,
dietary and diabetes risk factors. This might be attributable to
lower statistical power of the multivariable model, although
differences in classification into low- and high-fat dairy may
also explain differences in findings to date, particularly as this
can be carried out by fat variety (full- and reduced-fat varieties
of dairy subtypes) or by absolute fat content.
Mechanisms In the current study, only dairy products that
have undergone fermentation were associated with reduced
risk of diabetes. Several potential mechanisms for such an
association exist. Menaquinones (vitamin K2) synthesised by
animal tissue are present in dairy products and have been
associated with reduced risk of type 2 diabetes [29].
Menaquinones can also be of microbiological origin and these
are found primarily in fermented foods. Probiotic bacteria,
also present in fermented dairy products, have been shown
to improve the lipid profile and antioxidant status in individ-
uals with type 2 diabetes [30, 31], and have beneficial effects
on cholesterol levels [32]. Moreover, these low-fat fermented
dairy products are naturally low in fat and high in water
content and are, therefore, low energy-dense foods. Studies
have shown an independent association of low energy-dense
foods with lower fasting insulin levels and the metabolic
syndrome [33] and a lower risk of type 2 diabetes [34].
Strengths and limitations To the best of our knowledge this is
the first study of dairy intake and type 2 diabetes to make use
of prospective food diary intake data, while past research has
used retrospective FFQ data. The detailed nature of food
diaries allows for differentiation between subtypes of dairy
intake, the inclusion of composite dishes in dairy intake esti-
mates and the identification of probable food choice alterna-
tives for inclusion in substitution analyses. Other strengths
include the large study size from which the cohort was drawn
and the medical verification of diabetes status using external
sources, which meant that loss to follow-up within the study
did not affect the completion of case ascertainment.
Limitations of this study warrant consideration. As dietary
intake was self-reported and collected prospectively for 7 days
the possibility of misreporting food intake and portion sizes
and/or changing usual dietary behaviours exists, in particular
through participant burden due to the detailed nature of food
diaries. However, accounting for energy misreporters in this
analysis had little effect on the associations found. We only
assessed diet once at baseline thus our estimates do not ac-
count for any dietary modifications over the follow-up period.
Dairy products consumed as minor ingredients in composite
dishes are not captured. Where fat content of individual prod-
ucts or specific brands differed substantially from the average
composition of the dairy product, misclassification into low-
and high-fat dairy categories may have occurred, however the
number of such products is likely to be low. Residual con-
founding and clustering of healthy behaviours cannot be to-
tally accounted for although the inclusion of a range of covar-
iates in the study allowed for adjustment for anthropometric,
lifestyle, other diabetes risk factors and dietary factors includ-
ing measured plasma vitamin C level. Furthermore, as the
study population is predominantly white European in origin
the findings cannot be generalised to other populations.
Conclusions In this large prospective study, greater low-fat
fermented dairy product intake, largely driven by yoghurt
intake, was associated with a decreased risk of type 2 diabetes.
These findings suggest that the consumption of specific dairy
types may be beneficial for the prevention of diabetes and
have implications, including the importance of considering
food group subtypes, for public health messages.
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